ʻaoʻao_banner

Nā huahana

2,3,5-Triphenyl-2H-tetrazolium chloride Cas:298-96-4 98% Keʻokeʻo/haeʻe melemele crystalline pauda

ʻO ka wehewehe pōkole:

Ka helu helu: XD90154
Cas: 298-96-4
ʻAno Molekala: C19H15N4·Cl
Kaumaha Molekala: 334.80
Loaʻa: Loaʻa
Kumukuai:  
Hoʻopili mua: 5g USD10
Pūʻulu Nui: Noi Manao

 

 

 

 

 

 

 


Huahana Huahana

Huahana Huahana

Helu Helu XD90154
inoa mea kūʻai 2,3,5-Triphenyl-2H-tetrazolium chloride
CAS 298-96-4
ʻĀpana Molekala C19H15N4·Cl
Kaumaha Molecular 334.80
Nā kikoʻī mālama 2 a 8 °C
Kānāwai Kūʻai Kūlike 29339980

 

Huahana Huahana

Ka nana aku Keʻokeʻo keʻokeʻo/melemele ʻeleʻele pauda
ʻO Assay Min.98%
Lae hehee 235 - 245 Deg C
Nalo ma ka maloo <3.0%
Waiwai 0.5% Max
Koena ma ka Ignition Max.0.5%
Solubility ma EtoH Holo
Solubility i loko o ka Ethanol Akaka a piha

 

 

No kaʻimiʻana i ka hopena maikaʻi o ka hui pūʻana o ka butyrate, Lactobacillus casei, a me L-carnitine i loko o keʻano colitis rat. Ua māheleʻia nāʻiole iʻehiku mau pūʻulu.ʻEhā mau pūʻulu i loaʻa i ka butyrate waha, L-carnitine, Lactobacillus casei a me ka hui pū ʻana o ʻekolu mau mea hana no 10 mau lā.ʻO nā hui i koe he mau mana maikaʻi ʻole a maikaʻi a me kahi hui hoʻopunipuni.Macroscopic, histopathological examinations, and biomarkers like tumor necrosis factor-alpha (TNF-α) and interlukin-1β (IL-1β), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), and ferric reduced ability of plasma (FRAP). ) ua hoʻoholo ʻia i loko o ke kolonā. Ua hōʻike ka hui ʻana i ka hopena maikaʻi loa i ka hoʻohaʻahaʻa ʻana i ka colitis i hoʻohālikelike ʻia me nā mana.Nā hoʻololi holoʻokoʻa i ka hōʻemi ʻana o TNF-α (114.66 ± 18.26 vs 171.78 ± 9.48 pg/mg protein, P <0.05), IL-1β (24.9 ± 1.07 vs 33.06 ± 2.16 pg/mg protein, P <0.0.05), TBARS ± 0.03 vs 0.49 ± 0.04 μg/mg protein, P <0.01), MPO (15.32 ± 0.4 vs 27.24 ± 3.84 U/mg protein, P <0.05), a me ke kiʻekiʻe o FRAP (23.46 ± 1.2 μL vs 1.2. , P <0.05) e kākoʻo i ka makemake o ka hui pūʻana i ka hoʻohālikelikeʻana i nā mana.ʻOiai ua ʻoi aku ka maikaʻi o nā monotherapies i ka hoʻomaikaʻi ʻana i nā hōʻailona colitis, ʻoi aku ka maikaʻi o ka hui ʻana i ka hoʻomaikaʻi ʻana i nā hōʻailona koʻikoʻi o ka colon oxidative e like me FRAP, TBARS, a me MPO. ke kahua lapaʻau.


  • Mua:
  • Aʻe:

  • Pani

    2,3,5-Triphenyl-2H-tetrazolium chloride Cas:298-96-4 98% Keʻokeʻo/haeʻe melemele crystalline pauda